|
|||||
|
|
A phase I study of carfilzomib in combination with ibrutinib for relapsed refractory mantle cell lymphoma |
|
| Authors: | Hun J Lee Jacob L Schmelz Fred Cramer Jorge E Romaguera Maria Badillo Michael Wang |
| Institution: | 1. Department of Lymphoma & Myeloma, MD Anderson Cancer Center, Houston, TX, USA;2. McGovern Medical School at UTHealth, Houston, TX, USA |
| Abstract: | |
| Keywords: | carfilzomib ibrutinib mantle cell lymphoma |